ArteraAI Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 136

Employees

  • Latest Deal Type
  • Mezzanine

  • Latest Deal Amount
  • $11.3M

  • Investors
  • 33

ArteraAI General Information

Description

Developer of AI-enabled predictive and prognostic cancer tests designed to identify patients who will benefit from therapy intensification. The company's tests leverage an algorithm that assesses digital images from a patient's biopsy and learns from a patient's clinical data, enabling clinicians with more information to make informed treatment decisions.

Contact Information

Website
www.artera.ai
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 108 1st Street
  • Los Altos, CA 94022
  • United States
+1 (650)
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Services
Corporate Office
  • 108 1st Street
  • Los Altos, CA 94022
  • United States
+1 (650)

ArteraAI Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ArteraAI Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Mezzanine 13-Mar-2026 $11.3M Completed Generating Revenue
3. Early Stage VC 01-Aug-2025 Completed Generating Revenue
2. Early Stage VC 01-Feb-2024 $20M $109M Completed Generating Revenue
1. Seed Round 21-Mar-2023 $89.5M $89.5M Completed Generating Revenue
To view ArteraAI’s complete valuation and funding history, request access »

ArteraAI Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed-3
Seed-2
Seed-1 7,168,458 $0.000010 $0.03 $0.03 1x $0.03 14.25%
To view ArteraAI’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

ArteraAI Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of AI-enabled predictive and prognostic cancer tests designed to identify patients who will benefit from thera
Decision/Risk Analysis
Los Altos, CA
136 As of 2026

San Diego, CA
 

Madison, WI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ArteraAI Competitors (26)

One of ArteraAI’s 26 competitors is CureMetrix, a Venture Capital-Backed company based in San Diego, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CureMetrix Venture Capital-Backed San Diego, CA
HealthMyne Formerly VC-backed Madison, WI
InsightRx Venture Capital-Backed San Francisco, CA
Decipher Urologic Cancers Formerly VC-backed San Diego, CA
PreciseDx Venture Capital-Backed New York, NY
You’re viewing 5 of 26 competitors. Get the full list »

ArteraAI Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ArteraAI Investors (33)

Investor Name Investor Type Holding Investor Since Participating Rounds
Eagle Point Trinity Senior Secured Lending Company BDC Mezzanine Minority
Trinity Capital Inc BDC Business Development Company Minority
EnvisionX Capital Venture Capital Minority
SCB 10X Corporate Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 33 investors. Get the full list »

ArteraAI FAQs

  • When was ArteraAI founded?

    ArteraAI was founded in 2021.

  • Where is ArteraAI headquartered?

    ArteraAI is headquartered in Los Altos, CA.

  • What is the size of ArteraAI?

    ArteraAI has 136 total employees.

  • What industry is ArteraAI in?

    ArteraAI’s primary industry is Decision/Risk Analysis.

  • Is ArteraAI a private or public company?

    ArteraAI is a Private company.

  • What is ArteraAI’s current revenue?

    The current revenue for ArteraAI is .

  • How much funding has ArteraAI raised over time?

    ArteraAI has raised $121M.

  • Who are ArteraAI’s investors?

    Eagle Point Trinity Senior Secured Lending Company BDC, Trinity Capital Inc BDC, EnvisionX Capital, SCB 10X, and are 5 of 33 investors who have invested in ArteraAI.

  • Who are ArteraAI’s competitors?

    CureMetrix, HealthMyne, InsightRx, Decipher Urologic Cancers, and PreciseDx are some of the 26 competitors of ArteraAI.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process